FDA Approves Cabozantinib for Differentiated Thyroid Cancer FDA Approves Cabozantinib for Differentiated Thyroid Cancer
The FDA has approved cabozantinib for the treatment of advanced/metastatic differentiated thyroid cancer after disease progression.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves Ruxolitinib for Treatment of Chronic GVHD FDA Approves Ruxolitinib for Treatment of Chronic GVHD
The US Food and Drug Administration has approved ruxolitinib (Jakafi) for the treatment of chronic graft-versus-host disease after failure of one or two lines of systemic therapy.FDA Approvals (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 22, 2021 Category: Transplant Surgery Tags: Hematology-Oncology News Alert Source Type: news

Long COVID Appears to'Impair' Survival in Cancer Patients Long COVID Appears to'Impair' Survival in Cancer Patients
Ongoing complications following SARS-CoV-2 infection are associated with increased risk for mortality and treatment cessation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Novel Virus Targeting Deadly Brain Tumors Shows Early Promise Novel Virus Targeting Deadly Brain Tumors Shows Early Promise
Early evidence suggests that an oncolytic virus engineered to kill malignant gliomas may improve survival.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cancer Risk After Radioiodine for Hyperthyroidism Is'Small'Cancer Risk After Radioiodine for Hyperthyroidism Is'Small '
New meta-analysis shows that radioactive iodine treatment for hyperthyroidism doesn't significantly increase cancer risk or cancer mortality in the vast majority of cases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

' Astonishing' PFS Improvement in Metastatic HER+ Breast Cancer'Astonishing' PFS Improvement in Metastatic HER+ Breast Cancer
Experts hail the"astonishing" improvement in progression-free survival reported with trastuzumab deruxtecan in HER2+ metastatic breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

First AI Pathology Program Approved: Helps Detect Prostate Cancer First AI Pathology Program Approved: Helps Detect Prostate Cancer
Paige Prostate was approved as an adjunct to pathologist review, not a replacement. It increases detection of cancer by an average of 7.3%.FDA Approvals (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 22, 2021 Category: Surgery Tags: Hematology-Oncology News Alert Source Type: news

Lung Cancer, Non-Hodgkin Lymphoma Biggest Contributors to Life-Years Lost to Cancer in Transplant Patients Lung Cancer, Non-Hodgkin Lymphoma Biggest Contributors to Life-Years Lost to Cancer in Transplant Patients
Transplant recipients have a shortened lifespan after developing cancer, especially those who develop lung cancer and non-Hodgkin lymphoma, according to a new analysis.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 22, 2021 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news

The Parent Penalty in Medicine The Parent Penalty in Medicine
Physicians starting a new family have to pay a heavy toll when they are not given the support they need by their departments and hospitals. Here's how an oncologist is looking to change all that.Medscape Blogs (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - September 22, 2021 Category: Universities & Medical Training Tags: Hematology-Oncology Blog Source Type: news

When Children and Teens With Cancer Get COVID-19 When Children and Teens With Cancer Get COVID-19
Global data on children and adolescents with cancer and COVID-19 shed light on risk factors associated with more severe illness.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approval for Tisotumab Vedotin in Advanced Cervical Cancer FDA Approval for Tisotumab Vedotin in Advanced Cervical Cancer
Tisotumab vedotin-tftv (Tivdak), an antibody-drug conjugate, has been granted accelerated approval for the treatment of recurrent or metastatic cervical cancer.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Mirati Drug Combination Shrinks Tumors in 39% of Patients in Colon Cancer Study Mirati Drug Combination Shrinks Tumors in 39% of Patients in Colon Cancer Study
A combination of adagrasib and older cancer drug Erbitux shrank tumors in 39% of patients with advanced colorectal cancer treated in a small trial.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 21, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Guideline Weakly Supports Trying Cannabinoids for Chronic Pain Guideline Weakly Supports Trying Cannabinoids for Chronic Pain
Do oral medical cannabis or cannabinoids work in chronic pain? Here's what the evidence says.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2021 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

Liberia: MoH to Screen Newborns for Sickle Cell Disease
[New Dawn] A team of experts from the hematology association in America is in partnership with Liberia to start screening newborns for sickle cell disease at the JFK hospital in Monrovia. (Source: AllAfrica News: Pregnancy and Childbirth)
Source: AllAfrica News: Pregnancy and Childbirth - September 21, 2021 Category: OBGYN Source Type: news

Survival Benefit With Pembro in TNBC, but Only for Subgroup Survival Benefit With Pembro in TNBC, but Only for Subgroup
New results show a survival benefit in a subgroup of women with triple-negative breast cancer (TNBC) when pembrolizumab (Keytruda) is added to chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 21, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Watchful Waiting in BCC: Which Patients Can Benefit? Watchful Waiting in BCC: Which Patients Can Benefit?
Some patients with basal cell carcinoma (BCC) may not need treatment. New data reveal who those patients likely are.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 20, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Call for a Move or Boycott of Big Texas Cancer Meeting Call for a Move or Boycott of Big Texas Cancer Meeting
Oncologists are calling for this year's San Antonio Breast Cancer Symposium to be moved out of Texas in response to the state's new abortion law, and a boycott of in-person attendance if no move happens.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 20, 2021 Category: Internal Medicine Tags: Hematology-Oncology News Source Type: news

Sharp Increase in Cancer Incidence and Mortality From 2020-2040 Sharp Increase in Cancer Incidence and Mortality From 2020-2040
Cancer incidence and mortality is expected to rise sharply in Europe between 2020 and 2040, albeit with wide variations between cancers, according to a new analysis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 20, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Men Give Thumbs Up to Video on Genetic Testing in Prostate Cancer Men Give Thumbs Up to Video on Genetic Testing in Prostate Cancer
A video about the risks and benefits of germline testing in prostate cancer could help cancer practices ease problems caused by a shortage of trained genetic counselors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Tanezumab May Reduce Intractable Bone Metastasis Pain Tanezumab May Reduce Intractable Bone Metastasis Pain
The monoclonal antibody tanezumab reduces cancer pain in patients already taking opioids but questions remain over the durability of its effect and its bone safety.Medscape News UK (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Androgen Deprivation Alone No Longer Acceptable for mCSPC Androgen Deprivation Alone No Longer Acceptable for mCSPC
Androgen deprivation alone is no longer an acceptable option for the treatment of men with metastatic castration-sensitive prostate cancer (mCSPC), experts contend.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Six Months of Trastuzumab Effective in HER2+ Breast Cancer Six Months of Trastuzumab Effective in HER2+ Breast Cancer
A large-scale data analysis has confirmed that 6 months of trastuzumab is just as effective as 12 months in HER2+ early breast cancer, but the question is whether it will be adopted, say experts.Medscape News UK (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Adjuvant Pembro Success in Early Melanoma Raises Questions Adjuvant Pembro Success in Early Melanoma Raises Questions
Adjuvant pembrolizumab significantly improved recurrence-free survival in stage 2B/C melanoma in KEYNOTE 716, but which patients benefit most and what does this mean for treatment down the line?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Standard of Care in Cervical Cancer New Standard of Care in Cervical Cancer
The combination resulted in significant improvements in both progression-free and overall survival compared with chemotherapy (with or without bevacizumab) alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

BrighTNess Follow-Up Data Shed Light on TNBC Therapy BrighTNess Follow-Up Data Shed Light on TNBC Therapy
Patients with triple negative breast cancer had improved event-free survival when carboplatin (but not the PARP inhibitor veliparib) was added to standard neoadjuvant chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 18, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pfizer Expands Recall of Antismoking Drug to Include All Lots Pfizer Expands Recall of Antismoking Drug to Include All Lots
Ongoing concerns over a nitrosamine impurity in Chantix prompt Pfizer to recall all batches of the product in the United States as a precautionary measure.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 17, 2021 Category: Cancer & Oncology Tags: Psychiatry News Source Type: news

Nivo/Ipi Combo Now'Standard of Care' in Mesothelioma Nivo/Ipi Combo Now'Standard of Care' in Mesothelioma
Patients with malignant pleural mesothelioma have a marked and sustained overall survival benefit with nivolumab and ipilimumab vs chemotherapy, even if they discontinue treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 17, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Flurry of Cancer Drug Endorsements From EU Panel Flurry of Cancer Drug Endorsements From EU Panel
The European Medicines Agency panel recommended for approval three new cancer drugs and additional indications for two other already marketed immunotherapies.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 17, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Improved Survival in Patients With NSCLC and Brain Metastases Improved Survival in Patients With NSCLC and Brain Metastases
About a third of the patients with NSCLC and brain metastases treated with atezolizumab in combination with chemotherapy had overall survival improved to 2 years.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 17, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Urgent' Need to Understand Immunotherapy De-escalation in NSCLC'Urgent' Need to Understand Immunotherapy De-escalation in NSCLC
The strong and durable response to immunotherapy in some patients suggests treatment could be reduced or withdrawn, but questions surround which patients will be ideal candidates, an expert argues.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 17, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Tackling Grief, Loss in Patients With Advanced Lung Cancer Tackling Grief, Loss in Patients With Advanced Lung Cancer
Managing distress in patients with a life-limiting condition is challenging, but physicians have a host of strategies at their fingertips to help provide relief, according to palliative care experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves First Oral Drug for NSCLC With EGFR Exon20 Insertion FDA Approves First Oral Drug for NSCLC With EGFR Exon20 Insertion
The FDA has granted an accelerated approval to mobocertinib for the treatment of locally advanced or metastatic nonsmall cell lung cancer with a specific type of EGFR mutation.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 16, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Patients Panic as Docs Cut Off Breast Cancer Drug Patients Panic as Docs Cut Off Breast Cancer Drug
Many women who have difficult-to-treat metastatic breast cancer and who have positively responded to atezolizumab suddenly had their prescription discontinued.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Locker Room' Talk About Death: Time for Oncologists to Stop'Locker Room' Talk About Death: Time for Oncologists to Stop
' Well, it's pretty clear he's going to die.'The brusque phrasing felt atypical coming from the otherwise gentle-hearted trainee.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Immunotherapy for Cancer Patients With Poor PS Needs a Rethink Immunotherapy for Cancer Patients With Poor PS Needs a Rethink
Use of check point inhibitors for patients with advanced cancer who have poor performance status (PS) needs a rethink, says editorialists.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 16, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Can Telemedicine Survive? Can Telemedicine Survive?
The future of telemedicine remains uncertain. Oncologist Jack West explores how we can give this approach staying power.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

The 9/11 Firefighters and Cancer Incidence:'We Owe Them'The 9/11 Firefighters and Cancer Incidence:'We Owe Them '
Whether or not the 9/11 firefighters are at increased risk for cancer, we owe them close and careful attention to their health, says Dr F. Perry Wilson.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

FDA Grants Zanubrutinib an Accelerated Approval in MZL FDA Grants Zanubrutinib an Accelerated Approval in MZL
The US Food and Drug Administration has granted an accelerated approval to zanubrutinib for the treatment of adult patients with relapsed or refractory marginal zone lymphoma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

New Tool Better Predicts Subsequent Cancers in Child Survivors New Tool Better Predicts Subsequent Cancers in Child Survivors
An eHealth cancer predisposition screening tool greatly increases the odds of predicting subsequent malignancies in childhood cancer survivors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

A Review of Sentinel Lymph Node Biopsy in Breast Cancer A Review of Sentinel Lymph Node Biopsy in Breast Cancer
What has recent research shown about the use of sentinel lymph node biopsy in breast cancer? This review provides an update.Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Severe Skin Reactions With Enfortumab Vedotin Severe Skin Reactions With Enfortumab Vedotin
Approved for metastatic urothelial cancer, the drug has now been associated with cases of severe skins reactions, some of which have been fatal.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Jeff Bridges Says COVID Made Cancer'Look Like A Piece of Cake'Jeff Bridges Says COVID Made Cancer'Look Like A Piece of Cake '
Actor Jeff Bridges, 71, said Monday that his lymphoma is in remission and that he is feeling better after contracting COVID-19. He was hospitalized for 5 weeks.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 14, 2021 Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news

Gluten-Free Diet May Reduce Cancer Risk in Celiac Disease Gluten-Free Diet May Reduce Cancer Risk in Celiac Disease
The increased risk for cancer among people with celiac disease decreased over time. It may be related to the beneficial effect of the gluten-free diet in the long term.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Screening and Treating H. Pylori in Those at High Risk for Gastric Cancer Appears Cost-Effective Screening and Treating H. Pylori in Those at High Risk for Gastric Cancer Appears Cost-Effective
Screening for and treating Helicobacter pylori infection in those at high risk for gastric cancer is cost effective, a new modeling study shows.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 14, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Active Surveillance for Prostate Cancer: Switch After 4 Years Active Surveillance for Prostate Cancer: Switch After 4 Years
Active surveillance instead of initial aggressive treatment has become a standard of care for men with low-risk prostate cancer, so why do they switch?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Oncologists Still Failing'Woefully' at Molecular Testing Oncologists Still Failing'Woefully' at Molecular Testing
Oncologist Jack West explores why molecular testing in advanced lung cancer is not happening often enough in the clinicMedscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 14, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Breast Cancer in Black Women: Physicians Do Not Know Enough Breast Cancer in Black Women: Physicians Do Not Know Enough
Breast cancer disproportionately limits the survival of Black women. We need to understand why.Medscape Blogs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 14, 2021 Category: Consumer Health News Tags: Hematology-Oncology Blog Source Type: news

Antibiotic Use and Colon Cancer: More Evidence of Link Antibiotic Use and Colon Cancer: More Evidence of Link
A Swedish population study appears to confirm recent data showing a link between antibiotic use and an increased risk for colon but not rectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 14, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Antipsychotics Tied to Increased Breast Cancer Risk Antipsychotics Tied to Increased Breast Cancer Risk
New research suggests that antipsychotics that increase prolactin are associated with an increased risk for breast cancer. However, an expert says that at this point, clinical implications are premature.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 13, 2021 Category: Cancer & Oncology Tags: Psychiatry News Source Type: news

Unequal Resource Distribution Underlies Lung Cancer Disparities Unequal Resource Distribution Underlies Lung Cancer Disparities
Lung cancer disparities are reversible, but it will take changes at the social policy and organizational levels to do it, says experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news